Alder commences ALD1910 dosing in Phase I migraine trial
Migraine is a neurological disease that causes recurrent moderate to severe headache episodes. Credit: Jose Navarro
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more